Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life - - BioPharm International

ADVERTISEMENT

Podcast :Using Stability Models to Predict Drug Characteristics at the End of Shelf Life



Peter Sprinz
PhD, Research Scientist,
Manufacturing Science & Technology—Statistics
Eli Lilly and Company

Add this Podcast feed to your media player



Using Stability Models to Predict Drug Characteristics at the End of Shelf Life

Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Listen to hear how Lilly has implemented such models, and what they have gained by doing so.



Related Links
Characterizing the Formulation Design Space
Best Practices for Formulation and Manufacturing of Biotech Drug Products
Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients

Click here to go to the main podcast page >>>

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here